Latest filing published 05 Jul 2018 for Oncology Venture Sweden AB, €970k.
Filing timeline
BuySaleInsider track record
Peter Buhl Jensen: trading record in brief
All filings by Peter Buhl Jensen on record concern Oncology Venture Sweden AB. We count 4 filings; the first trade dates from 8 March 2017 and the latest from 29 June 2018.
The open-market record consists of 3 sales worth €1.7M, with no purchase. Since January 2018: no purchases and 3 sales on the market.
The latest filing, published on 5 July 2018, reports an open-market sale of €970k in Oncology Venture Sweden AB. Filings reach the Finansinspektionen feed a median of 3 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter Buhl Jensen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 662,038 shares@ SEK 15.3152.5% of flowISIN SE0007157409FI:csv-6316500835c296cd0f6e
- 465,500 shares@ SEK 15.6338.2% of flowISIN SE0007157409FI:csv-dcda011ec29bac150b21
- 41,000 shares@ SEK 16.633.6% of flowISIN SE0007157409FI:csv-ddbb3b258e5ef91296e3
- 100,000 shares@ SEK 10.005.7% of flowISIN SE0007157409FI:csv-4d00e50a634334add265
4 of 4 declarations